Renzo Alfini
Renzo Alfini publishes mostly in Infectious Diseases, Organic Chemistry and Endocrinology, on topics such as Escherichia coli research studies, Viral gastroenteritis research and epidemiology and Bacterial Infections and Vaccines.
- World rank
- #1,573,465 of 7,710,434 ranked researchers
- Rank in Italy
- #51,272 of 242,206
- Works
- 61
- Citations
- 1.2k
- Citations per work
- 19.4
What does Renzo Alfini research?
Renzo Alfini's work is mostly in Medicine (26%), Chemistry (18%), Biochemistry, Genetics and Molecular Biology (17%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences2134.9%
- Health Sciences1625.6%
- Medicine1625.6%
- Everything else1321.5%
- Physical Sciences1118.0%
- Chemistry1118.0%
- 1Infectious Diseases19% of their works
- 2Organic Chemistry18% of their works
- 3Endocrinology17% of their works
- 4Microbiology10% of their works
- 5Food Science8% of their works
- 6Epidemiology7% of their works
Research topics
- Escherichia coli research studies
- Viral gastroenteritis research and epidemiology
- Bacterial Infections and Vaccines
- Salmonella and Campylobacter epidemiology
- Pneumonia and Respiratory Infections
- Clostridium difficile and Clostridium perfringens research
- Immune Response and Inflammation
- Chemical Synthesis and Reactions
Which keywords describe Renzo Alfini's research?
The keywords of their largest research topics: Epidemiology, Pathogenesis, Pathogenicity, Vaccine, Infection, Escherichia coli, Virulence and Antimicrobial Resistance.
- Pattern Recognition Receptors
- Catalysis
- Antibiotic-Associated Diarrhea
- Community-Acquired Pneumonia
- Campylobacter
- Bacterial Meningitis
- Rotavirus
- Antimicrobial Resistance
- Escherichia coli
- Vaccine
- Pathogenesis
- Epidemiology
- Pathogenicity
- Infection
- Virulence
- Norovirus
- Clinical Practice Guidelines
- Neisseria meningitidis
- Salmonella
- Pneumococcal Conjugate Vaccine
- Fecal Microbiota Transplantation
- Oxidation
- Toll-like Receptors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Epidemiology735 topics
- Pathogenesis412 topics
- Pathogenicity412 topics
- Vaccine412 topics
- Infection382 topics
- Escherichia coli271 topic
- Virulence271 topic
- Antimicrobial Resistance242 topics
- Norovirus241 topic
- Rotavirus241 topic
- Clinical Practice Guidelines182 topics
- Bacterial Meningitis171 topic
- Neisseria meningitidis171 topic
- Campylobacter141 topic
- Salmonella141 topic
- Community-Acquired Pneumonia101 topic
- Pneumococcal Conjugate Vaccine101 topic
- Antibiotic-Associated Diarrhea81 topic
- Fecal Microbiota Transplantation81 topic
- Catalysis41 topic
- Oxidation41 topic
- Pattern Recognition Receptors41 topic
- Toll-like Receptors41 topic
Where does Renzo Alfini work?
Renzo Alfini's main affiliation in the publication record is Toscana Life Sciences, Italy.
How many publications and citations does Renzo Alfini have?
OpenAlex counts 61 works and 1,182 citations for Renzo Alfini, an h-index of 19, ranking #1,573,465 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Renzo Alfini. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.